Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Digest.
Press releases published on March 25, 2025
Cogent Biosciences Announces Multiple Poster Presentations at 2025 American Association for Cancer Research (AACR) Annual Meeting
GlobeNewswire
·
March 25, 2025
WALTHAM, Mass. and BOULDER, Colo., March 25, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced four preclinical poster …
Zymeworks to Present Preclinical Data on T cell Engager and Antibody-Drug Conjugate Platforms in Six Posters at AACR Annual Meeting
GlobeNewswire
·
March 25, 2025
Novel trispecific T cell engager, ZW209, demonstrates potent preclinical efficacy against DLL3-expressing tumors and an encouraging safety profile New antibody-drug conjugate (ADC) candidate, ZW327, exhibits anti-tumor activity and a favorable …
T-knife Therapeutics Announces Five Presentations at American Association for Cancer Research (AACR) Annual Meeting
GlobeNewswire
·
March 25, 2025
Multiple presentations demonstrate that T-knife’s proprietary next-generation technologies address important challenges with current cell therapy constructs, including boosting T cell fitness and persistence within an immunosuppressive tumor …
Tango Therapeutics to Highlight Preclinical Data on Precision Oncology Pipeline with Five Posters at the American Association for Cancer Research (AACR) Annual Meeting 2025
GlobeNewswire
·
March 25, 2025
BOSTON, March 25, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that five abstracts have …
Tempest Announces Amezalpat Poster Presentation at the 2025 American Association for Cancer Research (AACR) Annual Meeting
GlobeNewswire
·
March 25, 2025
BRISBANE, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated therapeutics to fight cancer, today announced that an abstract …
Quanta Therapeutics Announces Late-Breaking Presentation of QTX3544, an Oral G12V-Preferring Multi-KRAS Inhibitor, at AACR Annual Meeting 2025
GlobeNewswire
·
March 25, 2025
SOUTH SAN FRANCISCO, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Quanta Therapeutics, a privately-held clinical-stage biopharmaceutical company leading the development of innovative, oral therapeutics for RAS-driven cancers, today announced it will give a …
Pyxis Oncology to Present New Preclinical Data Supporting Development of First-In-Concept ADC Targeting EDB+FN in Tumor Microenvironment at AACR 2025
GlobeNewswire
·
March 25, 2025
Expression data from patient-derived xenograft (PDX) mouse models exposed to micvotabart pelidotin (MICVO) indicate gene signatures associated with efficacy, deepening understanding of MOA and potential patient response Combination of a mouse analog of …
Polyrizon Expands Drug Delivery Innovation with Preclinical Studies for Epilepsy Rescue Treatment
GlobeNewswire
·
March 25, 2025
Raanana, Israel, March 25, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative intranasal hydrogels, announced today the initiation of …
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
GlobeNewswire
·
March 25, 2025
Soquelitinib Atopic Dermatitis Phase 1 Clinical Trial Data From Cohorts 1-3 anticipated to be Presented in May Initial Results From First Two Cohorts Supports Safety and Efficacy with Oral Agent and Novel Mechanism of Action Registration Phase 3 Clinical …
Rakovina Therapeutics Unveils Preclinical Data at the AACR - World’s Premier Cancer Research Forum
GlobeNewswire
·
March 25, 2025
VANCOUVER, British Columbia, March 25, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered drug discovery, today …
AmiViz Partners With Kiteworks to Empower Enterprises to Protect Their Most Sensitive Data
EIN Presswire
·
March 25, 2025
DUBAI , DUBAI, UNITED ARAB EMIRATES, March 25, 2025 /EINPresswire.com/ -- AmiViz, the leading cybersecurity-focused value-added distributor headquartered in the Middle East, has forged a strategic partnership with Kiteworks, which empowers organizations …
The Ultimate Gathering for Bitumen, Base Oil, Lubricants & Logistics: ABBL Bangkok & AMEA Dubai 2025
EIN Presswire
·
March 25, 2025
Connecting the Dots in Global Bitumen, Base Oil, Lubricants …
Nova Maldives and PADI Partner for a Transformative Ocean Adventure Week with India Black This July
EIN Presswire
·
March 25, 2025
NOVA MALDIVES, MALDIVES, March 25, 2025 /EINPresswire.com/ -- This summer, Nova Maldives, the soulful island resort, is proudly partnering with the world’s leading scuba diving organisation, PADI, to host a unique ocean adventure week from 13 to 20 July …
Bulla and TCS Blockchain driving onchain finance at the Mid-America Trucking Show
EIN Presswire
·
March 25, 2025
The Bulla TCS Blockchain settlement solution is now delivering savings, speed and transparency in trade finance DENVER, CO, UNITED STATES, March 24, 2025 /EINPresswire.com/ -- Bulla Network, an onchain working capital and finance platform and TCS …
AGII Reinforces Blockchain Integrity with Scalable AI Risk Detection Models
EIN Presswire
·
March 25, 2025
The platform expands its AI capabilities to proactively identify and mitigate threats in decentralized ecosystems. SEATTLE, WA, UNITED STATES, March 25, 2025 /EINPresswire.com/ -- AGII, a leading AI and Web3 platform, has announced the integration of …
Psyence Group's NASDAQ-Listed Associate, Psyence Biomedical, Further Strengthens Scientific Advisory Board With Appointment of Dr. Dan J. Stein
GlobeNewswire
·
March 25, 2025
TORONTO, March 25, 2025 (GLOBE NEWSWIRE) -- Psyence Group Inc ("Psyence Group" or the "Company") (CSE: PSYG) is pleased that its NASDAQ-listed associate, Psyence Biomedical Ltd (NASDAQ: PBM) ("PBM" or "Psyence Biomed"), has announced that it has expanded …
ذواكر DDR5 للألعاب/كسر السرعة مع ألوان جديدة، وزمن استجابة أقل، وإصدارات محسّنة لمنصة AMD
EIN Presswire
·
March 25, 2025
أداء فائق السرعة مع تصميم بسيط مثالي للاعبين والمبدعين HONG KONG, March 25, 2025 /EINPresswire.com/ -- KLEVV، العلامة التجارية الرائدة في مجال ذواكر التخزين للمستهلكين والتي أطلقتها Essencore، عن تحديثات مثيرة في مجموعة ذواكر DDR5 للألعاب وكسر السرعة ( …
CYREBRO Recognized in Gartner Emerging Tech Report for Detection and Response Startups
GlobeNewswire
·
March 25, 2025
RAMAT GAN, Israel, March 25, 2025 (GLOBE NEWSWIRE) -- CYREBRO, the AI-native Managed Detection and Response (MDR), today announced its recognition as a leading detection and response startup in the Gartner report, Emerging Tech: Techscape for Detection and …
Silynxcom Secures $300,000 Order from Elite European Special Forces Unit for Advanced In-Ear Communication Systems
GlobeNewswire
·
March 25, 2025
Silynxcom Announces Follow-on Order Strengthening Market Leadership; the Company Continues to Expand European Defense Market Penetration as Regional Military Spending Surges to Record Levels Netanya, Israel, March 25, 2025 (GLOBE NEWSWIRE) -- Silynxcom Ltd …
Helicore Biopharma Announces First Participant Dosed in Phase 1 Clinical Trial of HCR-188, a First-in-Class GIP Antagonist for the Treatment of Obesity
GlobeNewswire
·
March 25, 2025
Helicore’s first-in-human study is designed to evaluate the safety and tolerability of HCR-188 in a single and multiple ascending dose study Top-line safety data anticipated in the second half of 2025 SOUTH SAN FRANCISCO, Calif., March 25, 2025 (GLOBE …